Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-1990 | 06-1990 | 03-1990 | 12-1989 | 09-1989 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | N/A | N/A | -8,686 | N/A |
| Depreciation Amortization | N/A | N/A | N/A | 195 | N/A |
| Other Working Capital | N/A | N/A | N/A | 1,421 | N/A |
| Operating Cash Flow | $N/A | $N/A | $N/A | $-7,071 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | 9,933 | N/A |
| Net Acquisitions | N/A | N/A | N/A | -67 | N/A |
| Investing Cash Flow | $N/A | $N/A | $N/A | $9,866 | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 0 | 0 | -1,758 | 0 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $-1,758 | $N/A |
| Beginning Cash Position | N/A | N/A | N/A | 2,389 | N/A |
| End Cash Position | N/A | N/A | N/A | 3,426 | N/A |
| Net Cash Flow | $N/A | $N/A | $N/A | $1,037 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | N/A | N/A | -7,071 | N/A |
| Free Cash Flow | 0 | 0 | 0 | -7,071 | 0 |